180 related articles for article (PubMed ID: 12774304)
1. Alpha 4 nicotinic acetylcholine receptor subunit links cholinergic to brainstem monoaminergic neurotransmission.
Cucchiaro G; Commons KG
Synapse; 2003 Sep; 49(3):195-205. PubMed ID: 12774304
[TBL] [Abstract][Full Text] [Related]
2. Role of the nucleus raphe magnus in antinociception produced by ABT-594: immediate early gene responses possibly linked to neuronal nicotinic acetylcholine receptors on serotonergic neurons.
Bitner RS; Nikkel AL; Curzon P; Arneric SP; Bannon AW; Decker MW
J Neurosci; 1998 Jul; 18(14):5426-32. PubMed ID: 9651224
[TBL] [Abstract][Full Text] [Related]
3. The dorsal raphe nucleus as a site of action of the antinociceptive and behavioral effects of the alpha4 nicotinic receptor agonist epibatidine.
Cucchiaro G; Chaijale N; Commons KG
J Pharmacol Exp Ther; 2005 Apr; 313(1):389-94. PubMed ID: 15608080
[TBL] [Abstract][Full Text] [Related]
4. Expression of fos protein in rat brain following administration of a nicotinic acetylcholine receptor agonist epibatidine.
Watanabe K; Hashimoto K; Nishimura T; Tsunashima K; Minabe Y
Brain Res; 1998 Jun; 797(1):135-42. PubMed ID: 9630573
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical characterisation of Fos-positive cells in brainstem monoaminergic nuclei following intracranial self-stimulation of the medial forebrain bundle in the rat.
Ishida Y; Nakamura M; Ebihara K; Hoshino K; Hashiguchi H; Mitsuyama Y; Nishimori T; Nakahara D
Eur J Neurosci; 2001 Apr; 13(8):1600-8. PubMed ID: 11328353
[TBL] [Abstract][Full Text] [Related]
6. Conditioned-fear stress increases Fos expression in monoaminergic and GABAergic neurons of the locus coeruleus and dorsal raphe nuclei.
Ishida Y; Hashiguchi H; Takeda R; Ishizuka Y; Mitsuyama Y; Kannan H; Nishimori T; Nakahara D
Synapse; 2002 Jul; 45(1):46-51. PubMed ID: 12112413
[TBL] [Abstract][Full Text] [Related]
7. Alpha-7 nicotinic receptor expression by two distinct cell types in the dorsal raphe nucleus and locus coeruleus of rat.
Bitner RS; Nikkel AL
Brain Res; 2002 May; 938(1-2):45-54. PubMed ID: 12031534
[TBL] [Abstract][Full Text] [Related]
8. The locus coeruleus nucleus as a site of action of the antinociceptive and behavioral effects of the nicotinic receptor agonist, epibatidine.
Cucchiaro G; Chaijale N; Commons KG
Neuropharmacology; 2006 Jun; 50(7):769-76. PubMed ID: 16460769
[TBL] [Abstract][Full Text] [Related]
9. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
Marks MJ; Meinerz NM; Drago J; Collins AC
Neuropharmacology; 2007 Sep; 53(3):390-405. PubMed ID: 17631923
[TBL] [Abstract][Full Text] [Related]
10. Reduced nicotinic receptor-mediated antinociception following in vivo antisense knock-down in rat.
Bitner RS; Nikkel AL; Curzon P; Donnelly-Roberts DL; Puttfarcken PS; Namovic M; Jacobs IC; Meyer MD; Decker MW
Brain Res; 2000 Jul; 871(1):66-74. PubMed ID: 10882784
[TBL] [Abstract][Full Text] [Related]
11. The identification of novel structural compound classes exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic efficacy in preclinical models of pain.
Meyer MD; Decker MW; Rueter LE; Anderson DJ; Dart MJ; Kim KH; Sullivan JP; Williams M
Eur J Pharmacol; 2000 Mar; 393(1-3):171-7. PubMed ID: 10771011
[TBL] [Abstract][Full Text] [Related]
12. Epibatidine: a nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters: in vitro and in vivo evidence in rats.
Sacaan AI; Menzaghi F; Dunlop JL; Correa LD; Whelan KT; Lloyd GK
J Pharmacol Exp Ther; 1996 Feb; 276(2):509-15. PubMed ID: 8632316
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antinociception by nicotinic receptor agonist epibatidine and adrenal medullary transplants in the spinal subarachnoid space.
Caban AJ; Hama AT; Lee JW; Sagen J
Neuropharmacology; 2004 Jul; 47(1):106-16. PubMed ID: 15165838
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
Sawamura S; Kingery WS; Davies MF; Agashe GS; Clark JD; Kobilka BK; Hashimoto T; Maze M
J Neurosci; 2000 Dec; 20(24):9242-51. PubMed ID: 11125002
[TBL] [Abstract][Full Text] [Related]
15. A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception.
Khan IM; Stanislaus S; Zhang L; Taylor P; Yaksh TL
J Pharmacol Exp Ther; 2001 Apr; 297(1):230-9. PubMed ID: 11259549
[TBL] [Abstract][Full Text] [Related]
16. Fos expression in pontomedullary catecholaminergic cells following rapid eye movement sleep-like episodes elicited by pontine carbachol in urethane-anesthetized rats.
Rukhadze I; Fenik VB; Branconi JL; Kubin L
Neuroscience; 2008 Mar; 152(1):208-22. PubMed ID: 18155849
[TBL] [Abstract][Full Text] [Related]
17. Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (+/-)-epibatidine in rats.
Curzon P; Nikkel AL; Bannon AW; Arneric SP; Decker MW
J Pharmacol Exp Ther; 1998 Dec; 287(3):847-53. PubMed ID: 9864263
[TBL] [Abstract][Full Text] [Related]
18. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits.
Marubio LM; del Mar Arroyo-Jimenez M; Cordero-Erausquin M; Léna C; Le Novère N; de Kerchove d'Exaerde A; Huchet M; Damaj MI; Changeux JP
Nature; 1999 Apr; 398(6730):805-10. PubMed ID: 10235262
[TBL] [Abstract][Full Text] [Related]
19. Alpha 2A-adrenergic receptors are present in lower brainstem catecholaminergic and serotonergic neurons innervating spinal cord.
Guyenet PG; Stornetta RL; Riley T; Norton FR; Rosin DL; Lynch KR
Brain Res; 1994 Feb; 638(1-2):285-94. PubMed ID: 7911062
[TBL] [Abstract][Full Text] [Related]
20. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
